Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2021
Cerebrospinal Fluid Iron-Ferritin Ratio as a Potential Progression Marker for Parkinson's DiseaseFabian Maass, Bernhard Michalke, Desiree Willkommen, et al.European Journal of Neurology|February 25, 2022
Plasma neurofilament light chain as a biomarker for fatal familial insomniaPeter Hermann, Sezgi Canaslan, Anna Villar-Piqué, et al.Frontiers in Aging Neuroscience|October 11, 2021
Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-SynucleinopathiesSezgi Canaslan, Matthias Schmitz, Anna Villar-Piqué, et al.Sub-Cellular Biochemistry|September 26, 2025
Diagnosis of Prion DiseasesTayyaba Saleem, Anna-Lisa Fischer, Sezgi Canaslan, et al.Journal of Neurology|December 12, 2024
Myelin basic protein and TREM2 quantification in the CSF of patients with Multiple System Atrophy and other Parkinsonian conditionsFabian Maass, Sezgi Canaslan, Christoph van Riesen, et al.Translational Neurodegeneration|March 14, 2023
α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathiesMatthias Schmitz, Niccolò Candelise, Sezgi Canaslan, et al.Journal of Neurochemistry|April 1, 2025
Alpha-Synuclein Demonstrates Varying Binding Affinities With Different Tau IsoformsAnna-Lisa Fischer, Matthias Schmitz, Tobias Thom, et al.Biomedicines|June 27, 2024
SIMOA Diagnostics on Alzheimer's Disease and Frontotemporal DementiaAthanasia Chatziefstathiou, Sezgi Canaslan, Eirini Kanata, et al.Molecular Neurobiology|June 18, 2022
Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob DiseaseMatthias Schmitz, Sezgi Canaslan, Juan Carlos Espinosa, et al.NPJ Parkinson'S Disease|February 18, 2026
Detection of alpha-synuclein seeding activity in tear fluid in patients with Parkinson's diseaseSezgi Canaslan, Matthias Schmitz, Fabian Maass, et al.Pageof 2